# Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults

> **NCT02725437** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 100 (actual)

## Conditions studied

- Clostridium Difficile Associated Disease

## Interventions

- **BIOLOGICAL:** Clostridium difficile Vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02725437
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2018-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02725437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02725437, "Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02725437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*